Hinge Health (NYSE:HNGE - Get Free Report)'s stock had its "sell (d)" rating reissued by equities research analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Other equities analysts have also recently issued research reports about the company. Evercore ISI lifted their target price on Hinge Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research note on Wednesday. Canaccord Genuity Group lifted their target price on Hinge Health from $52.00 to $61.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Stifel Nicolaus lifted their target price on Hinge Health from $63.00 to $66.00 and gave the company a "buy" rating in a research note on Thursday, September 11th. Bank of America lifted their target price on Hinge Health from $42.00 to $64.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, KeyCorp lifted their target price on Hinge Health from $45.00 to $60.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Hinge Health has an average rating of "Moderate Buy" and an average target price of $57.47.
View Our Latest Analysis on Hinge Health
Hinge Health Stock Performance
NYSE:HNGE opened at $53.81 on Wednesday. Hinge Health has a fifty-two week low of $33.42 and a fifty-two week high of $62.18. The firm's 50-day simple moving average is $55.05.
Institutional Investors Weigh In On Hinge Health
A number of large investors have recently added to or reduced their stakes in HNGE. Montag A & Associates Inc. acquired a new stake in shares of Hinge Health in the second quarter worth $41,000. SBI Securities Co. Ltd. bought a new stake in Hinge Health in the 2nd quarter valued at $48,000. PNC Financial Services Group Inc. bought a new position in shares of Hinge Health during the 2nd quarter worth about $71,000. Emerald Advisers LLC acquired a new position in shares of Hinge Health during the second quarter valued at about $108,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Hinge Health in the second quarter valued at about $114,000.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
